C-Level Fireside Chat: Reflecting on Lessons from TCR Therapies to Drive Next-Generation Strategies

• Identifying pivotal learnings that can sharpen development strategies and accelerate stronger clinical outcomes
• Framing actionable insights that translate early proof-of-concept gains into durable, real-world clinical impact
• Exploring critical knowledge gaps and defining high-value priorities that can shape the next-generation of TCR innovations

Speakers:

Annelise vuidepot

Senior Vice President, Chief Science & Technology Officer

Immunocore

Luise Weigand

Chief Scientific Officer

Zelluna Immunotherapy

Peggy Sotiropoulou

CSO

T-knife Therapeutics

Cedrik Britten

CMO

Immatics

Reagan Jarvis

Chief Executive Officer & Co-Founder

Anocca